These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7967056

  • 1. [Hereditary spherocytosis associated with non-Hodgkin's lymphoma in the spleen].
    Arisawa K, Morita S, Kojima H, Inui A, Yoshino G, Hayashi Y, Kasuga M.
    Rinsho Ketsueki; 1994 Sep; 35(9):871-5. PubMed ID: 7967056
    [Abstract] [Full Text] [Related]

  • 2. [Retroperitoneal malignant lymphoma showing follicular type: report of a case].
    Terao T, Fujii Y, Ikeda I, Masuda M, Hirokawa M, Iwabuchi K, Maeda T, Asakura S.
    Hinyokika Kiyo; 1992 Oct; 38(10):1151-5. PubMed ID: 1481774
    [Abstract] [Full Text] [Related]

  • 3. [Follicular lymphoma in two brothers].
    Asahi A, Okamoto S, Matsushita H, Hattori Y, Takayama N, Ikeda Y.
    Rinsho Ketsueki; 2001 May; 42(5):408-13. PubMed ID: 11452461
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of primary non-Hodgkin's lymphoma of the vagina with chemotherapy.
    Engin H, Türker A, Abali H, Uner A, Günalp S.
    Arch Gynecol Obstet; 2004 Mar; 269(3):208-10. PubMed ID: 12904985
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
    López-Guillermo A, García-Conde J, Alvarez-Carmona AM, León P, Maldonado J, Alcalá A, Zubizarreta A, Sancho-Tello R, Carbonell F, Contreras E, Besses C, Hernando A, Fontanillas M, Montserrat E.
    Med Clin (Barc); 1998 May 09; 110(16):601-4. PubMed ID: 9656196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK, Gadre SA, Ge Y, Lockhart LH, Velagaleti GV.
    Eur J Haematol; 2007 Feb 09; 78(2):152-6. PubMed ID: 17313561
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Spontaneous splenic rupture in a case of non-Hodgkin's lymphoma].
    Dobashi N, Kuraishi Y, Kobayashi T, Hirano A, Isogai Y, Takagi K.
    Rinsho Ketsueki; 1993 Feb 09; 34(2):190-3. PubMed ID: 8492417
    [Abstract] [Full Text] [Related]

  • 12. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
    Saito S, Hayashi K, Ohnoshi T, Kawashima K, Matsutomo S, Tagawa S, Yoshino T, Nishiuchi R, Kimura I.
    Rinsho Ketsueki; 1994 Jul 09; 35(7):676-81. PubMed ID: 8065020
    [Abstract] [Full Text] [Related]

  • 13. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M, Karjalainen-Lindsberg ML, Nyman H, Eerola LM, Leppä S.
    Clin Cancer Res; 2007 Oct 01; 13(19):5784-9. PubMed ID: 17908969
    [Abstract] [Full Text] [Related]

  • 14. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 15. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM.
    Ann Rheum Dis; 2006 Aug 01; 65(8):1033-7. PubMed ID: 16322082
    [Abstract] [Full Text] [Related]

  • 16. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM.
    Clin Cancer Res; 2000 Dec 01; 6(12):4950-6. PubMed ID: 11156256
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Boué F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F, Billaud E, Raphael M, Lancar R, Costagliola D.
    J Clin Oncol; 2006 Sep 01; 24(25):4123-8. PubMed ID: 16896005
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.